Skip to main content
Premium Trial:

Request an Annual Quote

Layoffs at 23andMe

23andMe has laid off about 100 employees from its consumer business, as GenomeWeb reports. It says that this represents about 14 percent of the overall 23andMe workforce.

CNBC traces this move to a decline in sales, and CEO Anne Wojcicki tells it that she was surprised by the turn in the market but notes privacy concerns could be a factor as could fears of a wider economic downturn. "This has been slow and painful for us," Wojcicki tells CNBC.

The Verge reports that other genetic testing companies have also noted a shrinking market. Illumina reported last year, it says, that there had been a decline in the direct-to-consumer genetic testing space and that Veritas Genomics recently paused its US operations and laid off staff. GenomeWeb also notes that Helix had layoffs and shifted its focus to population genomics partnerships.

Privacy has also been an increasing concern for the field, as people have become worried about how their data could be used, CNBC adds. 

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.